{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T20:15:59Z","timestamp":1790626559432,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NIA"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.bbi.2016.06.008","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T02:24:44Z","timestamp":1466907884000},"page":"10-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation"],"prefix":"10.1016","volume":"59","author":[{"given":"Haidar","family":"Shamran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth E.","family":"Zumbrun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis D.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj K.","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitzi","family":"Nagarkatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash S.","family":"Nagarkatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Udai P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbi.2016.06.008_b0005","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1124\/jpet.114.213306","article-title":"Role of microRNAs in resveratrol-mediated mitigation of colitis-associated tumorigenesis in Apc(Min\/+) mice","volume":"350","author":"Altamemi","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2016.06.008_b0010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2016.06.008_b0015","first-page":"419","article-title":"Relationship between serum RANTES levels and radiological progression in rheumatoid arthritis patients treated with methotrexate","volume":"17","author":"Boiardi","year":"1999","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bbi.2016.06.008_b0020","first-page":"135","article-title":"Immune mechanisms in chronic inflammatory bowel disease","volume":"72","author":"Braegger","year":"1994","journal-title":"Ann. Allergy"},{"key":"10.1016\/j.bbi.2016.06.008_b0025","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.4049\/jimmunol.154.5.2434","article-title":"Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation","volume":"154","author":"Casini-Raggi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2016.06.008_b0030","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1124\/jpet.110.169946","article-title":"Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1\/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice","volume":"334","author":"Cluny","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2016.06.008_b0035","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.3748\/wjg.v18.i34.4629","article-title":"MicroRNAs in inflammatory bowel disease\u2013pathogenesis, diagnostics and therapeutics","volume":"18","author":"Coskun","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bbi.2016.06.008_b0040","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1096\/fj.05-4943fje","article-title":"Up-regulation of anandamide levels as an endogenous mechanism and a pharmacological strategy to limit colon inflammation","volume":"20","author":"D\u2019Argenio","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.bbi.2016.06.008_b0045","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1053\/gast.2000.16500","article-title":"Mice deficient in Th1- and Th2-type cytokines develop distinct forms of hapten-induced colitis","volume":"119","author":"Dohi","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbi.2016.06.008_b0050","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.4049\/jimmunol.157.5.2174","article-title":"Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance","volume":"157","author":"Elson","year":"1996","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2016.06.008_b0055","first-page":"89","article-title":"Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis","volume":"61","author":"Engel","year":"2010","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.bbi.2016.06.008_b0060","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbi.2016.06.008_b0065","doi-asserted-by":"crossref","first-page":"e52782","DOI":"10.1371\/journal.pone.0052782","article-title":"Up-regulation of microRNA-126 may contribute to pathogenesis of ulcerative colitis via regulating NF-kappaB inhibitor IkappaBalpha","volume":"7","author":"Feng","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2016.06.008_b0070","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1046\/j.1440-1746.2001.02558.x","article-title":"Expression of B7 costimulatory molecules by cells infiltrating the colon in experimental colitis induced by oral dextran sulfate sodium in the mouse","volume":"16","author":"Grose","year":"2001","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbi.2016.06.008_b0075","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nature09267","article-title":"Mammalian microRNAs predominantly act to decrease target mRNA levels","volume":"466","author":"Guo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2016.06.008_b0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00004836-199503000-00010","article-title":"Serum interleukin-6 is related to disease activity but not disease specificity in inflammatory bowel disease","volume":"20","author":"Holtkamp","year":"1995","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.bbi.2016.06.008_b0085","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1136\/gutjnl-2012-304213","article-title":"MiR-141 Regulates colonic leukocytic trafficking by targeting CXCL12beta during murine colitis and human Crohn\u2019s disease","volume":"63","author":"Huang","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.bbi.2016.06.008_b0090","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bbrc.2008.11.043","article-title":"Foxo1 increases pro-inflammatory gene expression by inducing C\/EBPbeta in TNF-alpha-treated adipocytes","volume":"378","author":"Ito","year":"2009","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbi.2016.06.008_b0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.phrs.2009.03.008","article-title":"Cannabinoids in intestinal inflammation and cancer","volume":"60","author":"Izzo","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbi.2016.06.008_b0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pharmthera.2009.12.005","article-title":"Cannabinoids and the gut: new developments and emerging concepts","volume":"126","author":"Izzo","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bbi.2016.06.008_b0105","first-page":"G75","article-title":"Enterocytes are the primary source of the chemokine ENA-78 in normal colon and ulcerative colitis","volume":"273","author":"Keates","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbi.2016.06.008_b0110","doi-asserted-by":"crossref","first-page":"G364","DOI":"10.1152\/ajpgi.00407.2005","article-title":"Agonists of cannabinoid receptor 1 and 2 inhibit experimental colitis induced by oil of mustard and by dextran sulfate sodium","volume":"291","author":"Kimball","year":"2006","journal-title":"Am. J. Physiol. \u2013 Gastrointestinal Liver Physiol."},{"key":"10.1016\/j.bbi.2016.06.008_b0115","doi-asserted-by":"crossref","first-page":"29044","DOI":"10.1074\/jbc.C110.156745","article-title":"SMAD2 is essential for TGF beta-mediated Th17 cell generation","volume":"285","author":"Malhotra","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2016.06.008_b0120","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI200419465","article-title":"The endogenous cannabinoid system protects against colonic inflammation","volume":"113","author":"Massa","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2016.06.008_b0125","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1053\/gast.2002.33584","article-title":"Evolving pathophysiologic models of functional gastrointestinal disorders","volume":"122","author":"Mayer","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbi.2016.06.008_b0130","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/PL00000223","article-title":"Tissue cytokine and chemokine expression in inflammatory bowel disease","volume":"50","author":"McCormack","year":"2001","journal-title":"Inflammation Res."},{"key":"10.1016\/j.bbi.2016.06.008_b0135","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1440-1746.1997.tb00375.x","article-title":"Selective depletion of neutrophils by a monoclonal antibody, RP-3, suppresses dextran sulphate sodium-induced colitis in rats","volume":"12","author":"Natsui","year":"1997","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbi.2016.06.008_b0140","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.clim.2003.09.013","article-title":"Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice","volume":"110","author":"Ogawa","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.bbi.2016.06.008_b0145","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbi.2016.06.008_b0150","doi-asserted-by":"crossref","first-page":"e0142869","DOI":"10.1371\/journal.pone.0142869","article-title":"Site-specific MicroRNA expression may lead to different subtypes in ulcerative colitis","volume":"10","author":"Ranjha","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbi.2016.06.008_b0155","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/gut.39.5.684","article-title":"Increased production of tumour necrosis factor-alpha interleukin-1 beta, and interleukin-6 by morphologically normal intestinal biopsies from patients with Crohn\u2019s disease","volume":"39","author":"Reimund","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.bbi.2016.06.008_b0160","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ejps.2013.11.012","article-title":"Inhibition of fatty acid amide hydrolase (FAAH) as a novel therapeutic strategy in the treatment of pain and inflammatory diseases in the gastrointestinal tract","volume":"52","author":"Salaga","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bbi.2016.06.008_b0165","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/ncpgasthep0528","article-title":"Mechanisms of disease: pathogenesis of Crohn\u2019s disease and ulcerative colitis","volume":"3","author":"Sartor","year":"2006","journal-title":"Nat. Clin. Pract. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bbi.2016.06.008_b0170","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2007.11.059","article-title":"Microbial influences in inflammatory bowel diseases","volume":"134","author":"Sartor","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbi.2016.06.008_b0175","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.4049\/jimmunol.1100922","article-title":"Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-\/- mice precedes expression in the colon","volume":"18","author":"Schaefer","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2016.06.008_b0180","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/1521-4141(200105)31:5<1465::AID-IMMU1465>3.0.CO;2-E","article-title":"Characterization of chemokines and chemokine receptors in two murine models of inflammatory bowel disease: IL-10-\/- mice and Rag-2-\/- mice reconstituted with CD4+CD45RBhigh T cells","volume":"31","author":"Scheerens","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbi.2016.06.008_b0185","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/imm.12328","article-title":"MiR-155 deficiency protects mice from experimental colitis by reducing Th1\/Th17 responses","volume":"143","author":"Singh","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.bbi.2016.06.008_b0190","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1124\/jpet.109.160838","article-title":"Resveratrol (trans-3,5,4\u2019-trihydroxystilbene) induces silent mating type information regulation-1 and down-regulates nuclear transcription factor-kappaB activation to abrogate dextran sulfate sodium-induced colitis","volume":"332","author":"Singh","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbi.2016.06.008_b0195","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.taap.2011.11.005","article-title":"Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-\/-) mice by attenuating the activation of T cells and promoting their apoptosis","volume":"258","author":"Singh","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.bbi.2016.06.008_b0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2172-9-25","article-title":"CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis","volume":"9","author":"Singh","year":"2008","journal-title":"BMC Immunol."},{"key":"10.1016\/j.bbi.2016.06.008_b0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/jir.2007.0059","article-title":"CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-\/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition","volume":"28","author":"Singh","year":"2008","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.bbi.2016.06.008_b0210","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4049\/jimmunol.171.3.1401","article-title":"Inhibition of IFN-gamma-inducible protein-10 abrogates colitis in IL-10(-\/-) mice","volume":"171","author":"Singh","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbi.2016.06.008_b0215","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.bbi.2016.06.008_b0220","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00109-008-0359-6","article-title":"Targeting endocannabinoid degradation protects against experimental colitis in mice: involvement of CB1 and CB2 receptors","volume":"86","author":"Storr","year":"2008","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bbi.2016.06.008_b0225","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/ibd.20960","article-title":"Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis","volume":"15","author":"Storr","year":"2009","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bbi.2016.06.008_b0230","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1172\/JCI30587","article-title":"The fundamental basis of inflammatory bowel disease","volume":"117","author":"Strober","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bbi.2016.06.008_b0235","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.immunol.20.100301.064816","article-title":"The immunology of mucosal models of inflammation","volume":"20","author":"Strober","year":"2002","journal-title":"Ann. Rev. Immunol."},{"key":"10.1016\/j.bbi.2016.06.008_b0240","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00915248","article-title":"The immunologic basis of inflammatory bowel disease","volume":"6","author":"Strober","year":"1986","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bbi.2016.06.008_b0245","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s10067-006-0387-y","article-title":"Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus","volume":"26","author":"Vila","year":"2007","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.bbi.2016.06.008_b0250","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/ibd.21450","article-title":"Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn\u2019s disease","volume":"17","author":"Wu","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"issue":"1624\u20131635","key":"10.1016\/j.bbi.2016.06.008_b0255","doi-asserted-by":"crossref","first-page":"e1624","DOI":"10.1053\/j.gastro.2008.07.068","article-title":"MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha","volume":"135","author":"Wu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bbi.2016.06.008_b0260","doi-asserted-by":"crossref","first-page":"9817","DOI":"10.1074\/jbc.M111.333534","article-title":"MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1","volume":"287","author":"Yin","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbi.2016.06.008_b0265","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.12869","article-title":"Down-regulation of microRNAs of the miR-200 family and up-regulation of Snail and Slug in inflammatory bowel diseases \u2013 hallmark of epithelial-mesenchymal transition","author":"Zidar","year":"2016","journal-title":"J. Cell Mol Med."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915911630188X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915911630188X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T21:22:37Z","timestamp":1740432157000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088915911630188X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":53,"alternative-id":["S088915911630188X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2016.06.008","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fatty acid amide hydrolase (FAAH) blockade ameliorates experimental colitis by altering microRNA expression and suppressing inflammation","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2016.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}